Yes, you can sell the same private label ceramide hyaluronic acid toner in both the US and the EU, but you must comply with each market's distinct regulatory framework, and a single formula often needs two separate compliance pathways running in parallel.
In the United States, cosmetics are regulated by the FDA under the Federal Food, Drug, and Cosmetic Act, now updated by the Modernization of Cosmetics Regulation Act (MoCRA) signed in December 2022. Under MoCRA, your brand (as the 'responsible person') must register the manufacturing facility and list every cosmetic product with the FDA annually. Registration is currently free via the FDA Unified Registration and Listing System (FURLS). You must also maintain safety substantiation records demonstrating that the product is safe under labeled conditions of use — your manufacturer's stability data and safety testing typically satisfy this requirement for a standard toner. Labeling must include an ingredient declaration in INCI order (descending by concentration), net contents in US units, and your brand's name and address.
In the European Union, cosmetics are regulated under Regulation (EC) No 1223/2009. Every cosmetic product sold in the EU must have a designated EU Responsible Person — a legal entity (company or individual) physically located in the EU/EEA who accepts regulatory liability for the product. As a non-EU brand, you need to appoint an EU Responsible Person before any product enters the EU market. The Responsible Person must compile and hold a Product Information File (PIF) that includes the formula, stability data, safety assessment signed by a qualified safety assessor, and manufacturing details. The product must also be notified through the EU Cosmetic Products Notification Portal (CPNP) before sale.
The EU ingredient restriction list (Annexes II through VI of Regulation 1223/2009) must be checked for every ingredient in your ceramide-HA toner. Ceramide NP, HA sodium salt, and most standard humectants are unrestricted. Preservatives, however, are regulated in Annex V — Phenoxyethanol is permitted up to 1.0%, which aligns with standard US usage levels. Fragrance allergens must be declared individually on the EU label if present above threshold concentrations (0.001% for leave-on products will change under the forthcoming fragrance regulation update).
From a practical standpoint, formulators who produce toners for both markets usually align the formula to the stricter of the two frameworks (generally EU), which means all EU-restricted ingredients are avoided upfront, and label copy is written conservatively to avoid drug-claim crossover in either jurisdiction. Claims like 'repairs the skin barrier' are acceptable as cosmetic claims; 'treats eczema' or 'cures dry skin disease' would trigger drug classification in both markets.
If you're planning dual-market launch from the start, mention this explicitly when you post your brief on AJ Cosmo Labs — some manufacturers have established EU Responsible Person partnerships and can streamline the compliance pathway, while others are US-only and will require you to arrange EU compliance independently.
Ingredients in this answer: Hyaluronic Acid · Phenoxyethanol · Ceramide NP
Read the full guide on Private Label Ceramide Hyaluronic Acid Toner Manufacturer →